Home LiteratureArticle Details
PMID: 8227335 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Early events of human T lymphocyte activation are associated with type I protein kinase A activity.

The Journal of clinical investigation ·Vol. 92 ·No. 5 ·1993-11-00 ·Pages 2207-14

Laxminarayana D, Berrada A, Kammer GM

Abstract

Human T lymphocytes possess both the type I and II isozymes of protein kinase A (PKA). The type I (PKA-I) isozyme is predominantly associated with the plasma membrane, whereas the type II (PKA-II) isozyme is primarily localized to the cytosol. Because the functions of both PKA-I and PKA-II isozymes in the biochemical events of T lymphocyte activation have not been clearly elucidated, we tested the hypothesis that very early events of normal human T lymphocyte activation are mediated by the PKA-I and/or PKA-II isozyme(s). Fresh normal human T cells and a normal human CD4+ T cell line (GK606) activated with anti-CD3-epsilon and recombinant interleukin 1 alpha (rIL-1 alpha) exhibited a peak six- to sevenfold increase of PKA phosphotransferase activity at 5 min that returned to baseline by 60 min. Similarly, both fresh T cells and the T cell line activated by phorbol myristate acetate and ionomycin demonstrated a peak eightfold increase of PKA activity by 15 min that returned toward baseline by 60 min. Chromatographic separation of the PKA isozymes and quantification of phosphotransferase activities after T cell activation by either agonist pair showed preferential activation of the PKA-I isozyme, resulting in a significant reduction in the ratio of PKA-I to PKA-II isozyme activity from 3.1:1-6.2:1 to 1.1:1-3.2:1. PKA-I isozyme activation resulted in the release of free catalytic (C) subunit, an increase in C subunit phosphotransferase activity, and the phosphorylation of T cell plasma membrane-associated proteins, p14, p17, p20, p21, p38, and p48. However, activation of the PKA-I isozyme did not appear to be required for the transcription of IL-2 mRNA, an event necessary for mitosis. These data indicate that ligand-induced T cell activation is associated with rapid activation of the PKA-I, but not PKA-II, isozyme that results in phosphorylation of plasma membrane-associated proteins. The involvement of the PKA-I isozyme during the very early events of T cell activation suggests that this isozyme may be an antigen- or mitogen-stimulated protein kinase.

MeSH Terms
Adenosine Monophosphate/analogs & derivatives,pharmacology Base Sequence CD3 Complex/immunology,metabolism Cell Membrane/metabolism Cyclic AMP/analogs & derivatives Cyclic AMP-Dependent Protein Kinase Type II Cyclic AMP-Dependent Protein Kinases/metabolism Humans Interleukin-1/pharmacology Ionomycin/pharmacology Isoenzymes/metabolism Lymphocyte Activation/drug effects Molecular Sequence Data Phosphorylation T-Lymphocytes/enzymology Tetradecanoylphorbol Acetate/pharmacology Thionucleotides/pharmacology Time Factors
Chemicals
CD3 Complex Interleukin-1 Isoenzymes Thionucleotides adenosine 5'-phosphorothioate Adenosine Monophosphate Ionomycin Cyclic AMP Cyclic AMP-Dependent Protein Kinase Type II Cyclic AMP-Dependent Protein Kinases Tetradecanoylphorbol Acetate
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Laxminarayana D
Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106.
Berrada A
Kammer G M
References (45)
45 references, click to expand
  1. Message amplification phenotyping (MAPPing): a technique to simultaneously measure multiple mRNAs from small numbers of cells.
    Biotechniques. 1989 Nov-Dec;7(10):1096-103 PMID: 2698190
  2. Phosphorylation of the spliced variant forms of the recombinant stimulatory guanine-nucleotide-binding regulatory protein (Gs alpha) by protein kinase C.
    Biochem J. 1992 Jul 1;285 ( Pt 1):333-8 PMID: 1637317
  3. Involvement of cyclic AMP-dependent protein kinases in the signal transduction pathway for interleukin-1.
    Mol Cell Biol. 1990 Jul;10(7):3824-7 PMID: 2192264
  4. Protein kinase C and Gi-protein mediated modulation of cAMP production in different stages of the rat seminiferous epithelium.
    Mol Cell Endocrinol. 1990 May 7;70(3):247-53 PMID: 2163336
  5. Differentiation of HL-60 leukemia by type I regulatory subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase.
    Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):2011-5 PMID: 2000408
  6. T cell antigen receptor activation pathways: the tyrosine kinase connection.
    Cell. 1991 Mar 8;64(5):875-8 PMID: 1848158
  7. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
    Anal Biochem. 1976 May 7;72:248-54 PMID: 942051
  8. Type I and type II cyclic AMP-dependent protein kinase as opposite effectors of lymphocyte mitogenesis.
    Nature. 1977 Jul 7;268(5615):63-4 PMID: 196201
  9. Correlated analysis of cellular DNA, membrane antigens and light scatter of human lymphoid cells.
    Cytometry. 1982 Mar;2(5):337-43 PMID: 6176404
  10. Inhibition of glucagon-induced glycogenolysis in isolated rat hepatocytes by the Rp diastereomer of adenosine cyclic 3',5'-phosphorothioate.
    J Biol Chem. 1984 Jul 10;259(13):8151-5 PMID: 6330102
  11. Capping of the surface OKT3 binding molecule prevents the T-cell proliferative response to antigens: evidence that this molecule conveys the activation signal.
    Cell Immunol. 1984 Aug;87(1):284-94 PMID: 6611213
  12. Regulation of the cellular and subcellular concentrations and distribution of cyclic nucleotide-dependent protein kinases.
    Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984;18:63-117 PMID: 6093482
  13. Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibody.
    Eur J Immunol. 1985 Jul;15(7):645-51 PMID: 3924633
  14. Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase.
    Eur J Biochem. 1985 Sep 2;151(2):431-7 PMID: 3161729
  15. Activators of protein kinase C down-regulate and phosphorylate the T3/T-cell antigen receptor complex of human T lymphocytes.
    Proc Natl Acad Sci U S A. 1985 Dec;82(23):8158-62 PMID: 3934668
  16. The protein kinase C activator phorbol-12-myristate-13-acetate enhances cyclic AMP accumulation in pheochromocytoma cells.
    FEBS Lett. 1986 Feb 3;196(1):131-4 PMID: 3002860
  17. Interleukin 1 and cyclic AMP induce kappa immunoglobulin light-chain expression via activation of an NF-kappa B-like DNA-binding protein.
    Mol Cell Biol. 1989 Mar;9(3):959-64 PMID: 2542770
  18. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response.
    Immunol Today. 1988 Jul-Aug;9(7-8):222-9 PMID: 2855581
  19. Plasmids encoding PKI(1-31), a specific inhibitor of cAMP-stimulated gene expression, inhibit the basal transcriptional activity of some but not all cAMP-regulated DNA response elements in JEG-3 cells.
    J Biol Chem. 1989 Nov 25;264(33):19506-13 PMID: 2479635
  20. Defective cAMP-dependent phosphorylation of intact T lymphocytes in active systemic lupus erythematosus.
    Proc Natl Acad Sci U S A. 1990 Mar;87(5):1978-82 PMID: 2155428
  21. Studies and perspectives of protein kinase C.
    Science. 1986 Jul 18;233(4761):305-12 PMID: 3014651
  22. A common pathway for T lymphocyte activation involving both the CD3-Ti complex and CD2 sheep erythrocyte receptor determinants.
    J Immunol. 1986 Aug 15;137(4):1097-100 PMID: 2426350
  23. Enhancement of adenylate cyclase activity in S49 lymphoma cells by phorbol esters. Withdrawal of GTP-dependent inhibition.
    J Biol Chem. 1986 Sep 15;261(26):12036-41 PMID: 2875069
  24. Antigen activation of murine T cells induces tyrosine phosphorylation of a polypeptide associated with the T cell antigen receptor.
    Cell. 1986 Sep 26;46(7):1083-90 PMID: 2428504
  25. Activation of adipocyte adenylate cyclase by protein kinase C.
    J Biol Chem. 1986 Nov 5;261(31):14534-8 PMID: 3771540
  26. Association of phosphorylation of the T3 antigen with immune activation of T lymphocytes.
    Nature. 1987 Feb 5-11;325(6104):540-2 PMID: 3100962
  27. Cross-talk between cellular signalling pathways suggested by phorbol-ester-induced adenylate cyclase phosphorylation.
    Nature. 1987 May 7-13;327(6117):67-70 PMID: 3033513
  28. The basis for the immunoregulatory role of macrophages and other accessory cells.
    Science. 1987 May 1;236(4801):551-7 PMID: 2437650
  29. T cell receptor tyrosine phosphorylation. Variable coupling for different activating ligands.
    J Biol Chem. 1987 Sep 15;262(26):12654-9 PMID: 3114259
  30. Cell surface molecules and early events involved in human T lymphocyte activation.
    Adv Immunol. 1987;41:1-38 PMID: 2961214
  31. Mobility of the human T lymphocyte surface molecules CD3, CD4, and CD8: regulation by a cAMP-dependent pathway.
    Proc Natl Acad Sci U S A. 1988 Feb;85(3):792-6 PMID: 2829202
  32. Selective activation of the cAMP-dependent protein kinase isoenzymes.
    Methods Enzymol. 1988;159:105-18 PMID: 2842579
  33. IL-1 signaling for IL-2 production in T cells involves a rise in phosphatidylserine synthesis.
    J Immunol. 1988 Nov 1;141(9):3078-80 PMID: 2844906
  34. Cyclic AMP--an intracellular second messenger for interleukin 1.
    Proc Natl Acad Sci U S A. 1988 Nov;85(21):8201-5 PMID: 2847154
  35. Contingent genetic regulatory events in T lymphocyte activation.
    Science. 1989 Jan 20;243(4889):355-61 PMID: 2783497
  36. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.
    Proc Natl Acad Sci U S A. 1989 Apr;86(7):2336-40 PMID: 2494664
  37. How does interleukin 1 activate cells? Interleukin 1 signal transduction.
    Immunol Today. 1990 Nov;11(11):392-4 PMID: 2150311
  38. Activation of AP-1 by IL-1 and phorbol esters in T cells. Role of protein kinase A and protein phosphatases.
    J Immunol. 1991 Aug 1;147(3):867-73 PMID: 1713607
  39. Modification of biological responses to interleukin-1 by agents that perturb signal transduction pathways.
    Cytokine. 1991 Jan;3(1):42-53 PMID: 1715770
  40. Investigation of guanine-nucleotide-binding protein involvement and regulation of cyclic AMP metabolism in interleukin 1 signal transduction.
    Biochem J. 1992 Feb 15;282 ( Pt 1):59-67 PMID: 1311561
  41. Phosphorylation of the inhibitory guanine-nucleotide-binding protein as a possible mechanism of inhibition by protein kinase C of agonist-induced Ca2+ mobilization in human platelet.
    Eur J Biochem. 1992 May 1;205(3):1003-9 PMID: 1576985
  42. Interleukin-1 induces protein tyrosine phosphorylation in T cells.
    Eur J Immunol. 1992 Jun;22(6):1391-6 PMID: 1376256
  43. Pharmacology of protein kinase inhibitors.
    Annu Rev Pharmacol Toxicol. 1992;32:377-97 PMID: 1605572
  44. Human T lymphocyte cAMP-dependent protein kinase: subcellular distributions and activity ranges of type I and type II isozymes.
    FASEB J. 1992 Jun;6(9):2735-41 PMID: 1319361
  45. Protein kinase C and T cell activation.
    Eur J Biochem. 1990 Apr 30;189(2):205-14 PMID: 2186905
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1993-11-00
Pages
2207-14
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC288400
Subset
IM
Grants
NIAMS NIH HHS · AR-39501 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com